CART Technique for Chronic Total Occlusions

The retrograde technique has significantly improved the success of percutaneous treatment of chronic total occlusions (CTO). After crossing a collateral channel, creating a connection between the anterograde and retrograde systems is key. The most common technique for this is reverse controlled antegrade and retrograde subintimal tracking (reverse CART). This technique involves inflating a balloon over an anterograde guidewire, followed by the retrograde crossing of the occlusion toward the anterograde guidewire.

Relación entre calidad del vaso distal y resultados en tratamiento percutáneo de las oclusiones totales crónicas

However, in some cases, this maneuver may fail. When that happens, after a failed reverse CART, the original CART technique (which involves retrograde ballooning of the occlusion followed by anterograde guidewire into the true distal lumen) could be a feasible alternative. Nevertheless, according to registries, its use in practice is limited (between 2% and 10.4%). The aim of this study is to assess the indications, procedural characteristics, and outcomes of this technique.

The study included patients who were subjected to a retrograde approach and the CART technique at a high-volume CTO center (University of Washington Medical Center). Researchers assessed technical and procedural success. CTOs were classified based on calcification and anatomical complexity using the J-CTO and PROGRESS-CTO scores.

Of the 1582 CTOs addressed over the study period, 38.1% required a retrograde approach. The original CART technique was used in 7.5% of those cases.

Read also: REPLICA-EPICA 18 Registry: Using IVL in Calcified Coronary Lesions.

The average age of the patients was 69.1±10.3 years; 93.3% of subjects were men, with an average ejection fraction of 53.6±10.1%. Additionally, 48.9% of the population had diabetes, and most patients had a history of angioplasty (84.4%) or myocardial revascularization surgery (68.9%). Treated CTOs were most frequently in the right coronary artery (48.9%) and 95.6% of the occlusions were over 20 mm long, with a prior failed attempt in 28.9% of cases.

On average, anatomical complexity was very high (J-CTO score of 3.6±0.9 and PROGRESS-CTO score of 1.9±0.7), with moderate to severe calcification in 95.6% of the cases. CART was used as the primary strategy in 42.2% of the cases. Its main indications were impenetrable CTOs in the anterograde direction (86.7%), failed reverse CART (28.9%), and aorto-ostial occlusions (11.1%). The collaterals used were venous grafts (62.2%), septal (24.4%), and contralateral epicardial collaterals (6.7%).

The CART technique was successful in 73.3% of the cases. Even when it was not, it facilitated a subsequent reverse CART in 41.7% of cases. Technical and procedural success was achieved in 85.7% of patients using a venous graft as a collateral and in 76.5% of cases in the No-Graft group.

Read also: Third Generation Balloon-Expandable and Self-Expanding Valves: TAVR Meta- Analysis.

In the total cohort, the technical and procedural success rate was 82.2%, with a perforations rate of 8.9%, including both Ellis type 1 (balloon hemostasis) and Ellis type 3 (requiring a coated stent).

Conclusions

Data from the University of Washington show the use of CART in 7.5% of all analyzed retrograde approaches, with a high rate of technical and procedural success—despite high baseline anatomical complexity—and significant safety, as no in-hospital deaths were reported.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions.

Reference: Moscardelli S, Kearney KE, Lombardi WL, Azzalini L. Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions. EuroIntervention. 2024 May 10;20(9):571-578. doi: 10.4244/EIJ-D-23-01082. PMID: 38726716; PMCID: PMC11067721.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI) remains a major clinical challenge. These...

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

The link between coffee consumption and arrhythmia has been met with contradicting recommendations. It is widely believed that caffeine could trigger atrial fibrillation (AF)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...